MRG-001 in Patients With Alcoholic Hepatitis

Status Not yet recruiting

Clinical Trial Summary

The goal of this study is to test MRG-001 (an experimental medication). The purpose of this trial is to assess the dose related safety, Pharmacokinetics, and Pharmacodynamics of MRG-001 in patients with severe alcoholic hepatitis (AH).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06307522
Study type	Interventional
Source	MedRegen LLC
Contact	Ali R Ahmadi, MD PhD
Phone	4437598563
Email	info@medregenco.com
Status	Not yet recruiting
Phase	Phase 2
Start date	September 1, 2024
Completion date	December 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04066179` - Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.	N/A
Completed	`NCT03732586` - Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00962442` - N-Acetylcysteine in Severe Acute Alcoholic Hepatitis	Phase 3
Recruiting	`NCT05018481` - HA35 Moderate Alcoholic Hepatitis (AH) Study	Early Phase 1
Completed	`NCT04544020` - Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)
Recruiting	`NCT04088370` - Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Completed	`NCT04235855` - EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?	N/A
Active, not recruiting	`NCT02344680` - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Completed	`NCT00851981` - Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease	Phase 2
Completed	`NCT04084522` - Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic Hepatitis	N/A
Completed	`NCT05840640` - Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis	Phase 4
Recruiting	`NCT03069300` - N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis	Phase 3
Terminated	`NCT02039219` - Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)	Phase 2
Completed	`NCT01245257` - Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis	N/A
Completed	`NCT02019056` - Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis	Phase 2
Completed	`NCT00388323` - Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human	N/A
Recruiting	`NCT03845205` - Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH	N/A
Recruiting	`NCT03703674` - GCSF in Alcoholic Hepatitis	Phase 4
Active, not recruiting	`NCT02473341` - Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial	Phase 3